Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH) Clinical Trials

2 recruiting trials for Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
1
Sponsors

Recruiting Trials

RECRUITINGNCT06850792

imprOving Adherence to Pulmonary artErial hyperteNsion Treatment With teLemedicIne and patieNt guidaNce

Pulmonary arterial hypertension (PAH) is a progressive condition with high morbidity, frequent hospitalizations, and risk of right heart failure. Despite advances in treatment,...

Sponsor: University of Sao Paulo General HospitalEnrolling: 611 location
RECRUITINGNCT07013149

The Impact of ERA Switching on Risk Stratification in Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is a rare, progressive, and potentially fatal disease characterized by increased pulmonary vascular resistance and right ventricular...

Sponsor: University of Sao Paulo General HospitalEnrolling: 1211 location